Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and patient care.

Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...

Lung cancer is the leading cause of cancer deaths worldwide, and early detection is key: there is a 12-fold increase in five-year survivorship between those detected at stage one versus stage four.

Breath analysis using VOCs shows promise for early NSCLC diagnosis, achieving 85% accuracy, 86.7% sensitivity, and 83.3% specificity. Current lung cancer diagnostic methods are invasive and costly, ...

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...

Results demonstrate the importance of ultra-sensitive ctDNA detection in lung cancer In this study, NeXT Personal was used to analyze pre-operative blood samples from a TRACERx cohort of 171 patients ...